Wells Fargo Maintains Equal-Weight on Relay Therapeutics, Raises Price Target to $6
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Eva Fortea Verdejo maintains Relay Therapeutics (NASDAQ:RLAY) with a Equal-Weight and raises the price target from $4 to $6.
Wells Fargo analyst Eva Fortea Verdejo maintains Relay Therapeutics (NASDAQ:RLAY) with a Equal-Weight and raises the price target from $4 to $6.